Larry C. Renfro Sells 22,184 Shares of UnitedHealth Group Inc (UNH) Stock

UnitedHealth Group Inc (NYSE:UNH) insider Larry C. Renfro sold 22,184 shares of the firm’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the transaction, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Shares of UNH stock opened at $226.78 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 1 year low of $162.74 and a 1 year high of $250.79. The company has a market cap of $220,491.67, a P/E ratio of 21.17, a P/E/G ratio of 1.33 and a beta of 0.74.

How to Become a New Pot Stock Millionaire

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.57 billion. During the same period last year, the company earned $2.11 EPS. The firm’s revenue was up 9.5% compared to the same quarter last year. analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.32%. UnitedHealth Group’s dividend payout ratio is presently 28.01%.

Several equities analysts have commented on UNH shares. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price on the stock in a report on Saturday, January 20th. Goldman Sachs started coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 target price on the stock. Credit Suisse Group raised their target price on shares of UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a report on Wednesday, January 17th. Cantor Fitzgerald reissued a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a report on Monday, December 25th. Finally, Piper Jaffray Companies raised their target price on shares of UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a report on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $245.14.

Large investors have recently bought and sold shares of the stock. Aevitas Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $102,000. Exane Derivatives boosted its position in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares during the period. Pathstone Family Office LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $129,000. Trustcore Financial Services LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $133,000. Finally, Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $114,000. Institutional investors and hedge funds own 86.78% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Stock Observer and is the property of of Stock Observer. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.thestockobserver.com/2018/03/21/larry-c-renfro-sells-22184-shares-of-unitedhealth-group-inc-unh-stock.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply